Abstract: A micro mirror device includes a hinge supported upon a substrate. The hinge has a length and a width substantially parallel to an upper surface of the substrate, and has a thickness substantially perpendicular to the upper surface of the substrate. The thickness is larger than the width. A mirror plate is tiltable around the hinge. The hinge can produce an elastic restoring force on the mirror plate when the mirror plate tilts away from an un-tilted position.

Abstract: A burner for use in a gas turbine engine includes a burner tube having an inlet end and an outlet end; a plurality of slots formed in the burner tube and configured to introduce air flows tangentially into the burner tube and impart swirl to the air flows; a plurality of fuel passages extending axially along the burner tube; and a plurality of fuel injection holes provided to each fuel passage. At least one of the fuel injection holes of each fuel passage is configured to inject a fuel flow tangentially into the burner tube between air flows of adjacent slots to form a fuel and air co-flow. A method of mixing air and fuel in a burner of a gas turbine is provided. The burner includes a burner tube including a plurality of slots formed in the burner tube. The method includes introducing air flows tangentially into the burner tube through the slots and imparting swirl to the air flows; and injecting fuel between air flows of adjacent slots to form fuel and air co-flows.

Abstract: A display system includes a coherent light source that can emit a coherent light beam, an optical component that can direct the coherent light beam to a spatial light modulator, a transport mechanism that can move the optical component to produce a movement in the coherent light beam, and a spatial light modulator having a two-dimensional array of mirrors each configured to selectively reflect the coherent light beam either toward a screen surface or away from the screen surface to form a display pixel on the screen surface. A display image is formed on the display screen by display pixels produced by the mirrors that reflect the coherent light beam toward the screen surface.

Abstract: Disclosed are novel compounds of the formula or a pharmaceutically acceptable salt or solvate thereof, wherein R1 is X is —O—, —C(R14)2— or —N(R)—; Z is —C(R14)2— or —N(R)—; t is 0, 1, 2 or 3; each R and R2 is independently H, alkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, alkenyl or alkynyl; each R14 is H, alkyl, alkenyl, alkynyl, halo, —CN, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, —OR35, —N(R24)(R25) or —SR35; R41 is alkyl, cycloalkyl, —SO2(alkyl), —C(O)-alkyl, —C(O)-cycloalkyl or -alkyl-NH—C(O)CH3; and the remaining variables are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds of formula I and methods of treating cognitive or neurodegenerative diseases with compounds of formula I.

Abstract: A loan syndication tracking and management system and method provides a user with access to specific details related to a syndicated loan. The system and method coordinates investor, borrower and resource information, in addition to features related to the overall structure of a syndicated loan. Users access the system with various levels of permissions to view, add, update or delete information according to their allotted permissions. The system permits multiple users to access the information for efficient handling of approvals and requests related to multiple investors and borrowers, in addition to handling institution interchanges and notifications. The system and method keeps a record of all transactions and changes for review, reporting or regulatory purposes. The administration of a syndicated loan transaction is simplified while providing advanced features such as support for loan trading.

Abstract: A method for synthesizing a photomask data set from a given target layout, including the following steps: (a) providing a set of target polygons for the target layout; (b) fitting a smooth curve to a target polygon of the set of target polygons, the curve having a set of etch-target points; (c) moving the etch target points according to a model of an etch process to produce a set of lithography-target points; and (d) synthesizing a photomask data set based on a model of a lithography process and the set of lithography-target points.

Abstract: The present invention is directed to processes for the synthesis of morphinans. In particular, a process for the asymmetric reduction of an imine moiety in a 3,4-dihydroisoquinoline to produce a tetrahydroisoquinoline, followed by a Birch reduction to produce a hexahydroisoquinoline. In various embodiments, the 3,4-dihydroisoquinoline contains a phenol moiety protected with a labile protecting group. In other embodiments, the imine reduction reaction mixture contains silver tetrafluoroborate.

Abstract: Systems and methods for providing a user with customized advertisements in response to a user indication of a desire to receive the customized advertisements. The user, by opting in and creating a user-controlled profile, indicates a desire to receive targeted and highly relevant advertisements that correspond to the user-specific information provided by the user in the user-controlled profile. This information, for example, may be the user's demographic information, location, marital status, information from the user's web-based calendar, or whether the user has children. The customized advertisements may also be selected according to the user's location, which may be determined by any location determining technique. By purchasing an item presented in a customized advertisement, referring a customized advertisement to another user, or taking some other defined action, the user may receive an incentive, such as points, currency, discounts, or credit to be used toward a future purchase.

Abstract: The present invention is directed to processes for the synthesis of morphinans. In particular, a process for coupling a carboxylic acid compound with an amine compound to form an amide product that can then be isolated or the crude amide product can be cyclized to form a 3,4-dihydroisoquinoline. In one embodiment, the carboxylic acid contains a phenol moiety protected with a labile protecting group. The protected phenol reduces reaction times, simplifies work-up of the product, and reduces the amount of cyclizing agent, POCl3 that is necessary to form the 3,4-dihydroisoquinoline.

Abstract: The present invention is directed to processes for the synthesis of morphinans. In particular, a process for coupling a carboxylic acid compound with an amine compound to form an amide product that can then be isolated or the crude amide product can be cyclized to form a 3,4-dihydroisoquinoline. In one embodiment, the carboxylic acid contains a phenol moiety protected with a labile protecting group. The protected phenol reduces reaction times, simplifies work-up of the product, and reduces the amount of cyclizing agent, POCl3 that is necessary to form the 3,4-dihydroisoquinoline.

Abstract: The present invention discloses novel peptide compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.

Abstract: A composition for promoting the formation of clots in blood comprises a binder and a zeolite disposed in the binder, the zeolite having an adjusted calcium content. A method of forming a blood-clotting composition comprises the steps of providing a zeolite, combining the zeolite with a binder, and adjusting a calcium content of the zeolite to have an amount of calcium such that upon application of the composition to a wound, a heat of hydration is reduced and thereby heat transferred to the wound is reduced. A method of clotting blood flowing from a wound comprises the steps of applying a zeolite to the wound and maintaining the zeolite in contact with the wound for a predetermined amount of time. The zeolite preferably has an adjusted calcium content and is capable of producing a controllable blood clotting effect on the wound.

Abstract: The present invention relates to adhesive polymer composites containing at least one nitrile rubber polymer having a Mooney viscosity (ML 1+4 @ 100° C.) below 30, optionally at least one filler and optionally at least one cross-linking agent, a process for preparing the polymer composite wherein at least one nitrile rubber polymer having a Mooney viscosity (ML 1+4 @ 100° C.) below 30, optionally at least one filler and optionally at least one cross-linking agent are mixed and a self-supporting shaped article containing the compound optionally layered on or interposed between one or more supporting means. The present invention also relates to a tape containing the adhesive polymer composite optionally layered on or interposed between one or more supporting means. Further, the present invention relates to a sealant composition containing the adhesive polymer composite.

Abstract: A surgical cassette having an aspiration chamber or infusion chamber with a sensing portion and a storage portion. The sensing portion has a small transverse cross sectional area and facilitates accurate fluid level measurements. The storage portion has a larger transverse cross sectional area to facilitate fluid storage.

Abstract: A method of booting a multi-processor data processing device includes establishing a link between a first processor and a memory. The link is monitored to determine if, in response to a request from the processor, expected initialization data is communicated between the memory and the first processor. If unexpected data is detected on the link, the link is severed and a new link established between a second processor and the memory to allow the second processor to initiate the boot process. This ensures that, in the event of an error in the boot process at the first processor, the device can complete the boot process, thereby reducing device downtime.

Abstract: The present invention provides a method for synthesizing 1-(acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amendable to scale-up. The current invention also provides 1-acyl-alkyl derivatives of known drug components and methods for synthesizing these 1-acyl-alkyl derivatives.

Abstract: The present invention provides for a process for preparing racemic methyl 6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylate, its corresponding salt: (2S, 3R, 4S)-methyl 6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylate di-p-toluoyl-D-tartaric acid (“D-DTTA”) salt or a (2R, 3S, 4R)-methyl 6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylate di-p-toluoyl-L-tartaric acid salt (“L-DTTA”) in a high enantiomeric excess. This invention also provides for a process for preparing a (2S, 3R, 4S)-methyl 6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylate dibenzoyl-D-tartaric acid (“D-DBTA”) salt or a (2R, 3S, 4R)-methyl 6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylate L-tartaric acid (“L-DBTA”) salt in a high enantiomeric excess. Further, this invention provides a process for preparing intermediates II, IIB, III, IV, IV salt, V, VI, and VII.

Abstract: The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.

Abstract: A technique for encoding 9-binary symbol (9B) source vectors into 10-binary symbol (10B) encoded vectors include the steps of obtaining a plurality of 9B source vectors, and encoding the 9B source vectors into a plurality of 10B encoded vectors according to an encoding scheme. A fraction of the 10B encoded data vectors have binary symbol changes, other than whole-vector complementation, compared to corresponding ones of the 9B source vectors, the fraction not including any disparity dependent encoded representations. Techniques for encoding 7B source vectors to 8B encoded vectors, and decoding techniques, are also provided.

Abstract: A compound having a formula is disclosed herein. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.